Global Plasma Therapeutics Market 2022-2026

Description

Technavio has been monitoring the plasma therapeutics market and it is poised to grow by $ 8.98 bn during 2022-2026 progressing at a CAGR of 6.1% during the forecast period. Our report on the plasma therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the high demand for albumin in China, increasing surgical procedures, and new approvals by governing bodies.

The plasma therapeutics market analysis includes the product segment and geographic landscape.

Technavio's plasma therapeutics market is segmented as below:

By Product

Immunoglobulin
Albumin
Blood factors
Others

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the establishment of plasma fractionation facilities in developing economies by global players as one of the prime reasons driving the plasma therapeutics market growth during the next few years. Also, strategic initiatives of vendors fueling the market growth and increasing awareness of the importance of early diagnosis will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on plasma therapeutics market covers the following areas:

Plasma therapeutics market sizing
Plasma therapeutics market forecast
Plasma therapeutics market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading plasma therapeutics market vendors that include ADMA Biologics Inc., Bio Products Laboratory Ltd., BIOPHARMA PLASMA, CSL Ltd., Emergent BioSolutions Inc., Evolve Biologics Inc., Grifols SA, Kamada Ltd., Kedrion Spa, Octapharma AG, Pfizer Inc., Prothya Biosolutions Netherlands BV, SK Discovery Co. Ltd., and Takeda Pharmaceutical Co. Ltd. Also, the plasma therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR73076

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
Exhibit 06: Executive Summary - Chart on Incremental Growth
Exhibit 07: Executive Summary - Data Table on Incremental Growth
Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 09: Parent market
Exhibit 10: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 11: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 12: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

4.1 Five forces summary
Exhibit 17: Five forces analysis - Comparison between2021 and 2026
4.2 Bargaining power of buyers
Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
4.3 Bargaining power of suppliers
Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
4.4 Threat of new entrants
Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
4.5 Threat of substitutes
Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
4.6 Threat of rivalry
Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
4.7 Market condition
Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Product

5.1 Market segments
Exhibit 24: Chart on Product - Market share 2021-2026 (%)
Exhibit 25: Data Table on Product - Market share 2021-2026 (%)
5.2 Comparison by Product
Exhibit 26: Chart on Comparison by Product
Exhibit 27: Data Table on Comparison by Product
5.3 Immunoglobulin - Market size and forecast 2021-2026
Exhibit 28: Chart on Immunoglobulin - Market size and forecast 2021-2026 ($ million)
Exhibit 29: Data Table on Immunoglobulin - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Chart on Immunoglobulin - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on Immunoglobulin - Year-over-year growth 2021-2026 (%)
5.4 Albumin - Market size and forecast 2021-2026
Exhibit 32: Chart on Albumin - Market size and forecast 2021-2026 ($ million)
Exhibit 33: Data Table on Albumin - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Chart on Albumin - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Albumin - Year-over-year growth 2021-2026 (%)
5.5 Blood factors - Market size and forecast 2021-2026
Exhibit 36: Chart on Blood factors - Market size and forecast 2021-2026 ($ million)
Exhibit 37: Data Table on Blood factors - Market size and forecast 2021-2026 ($ million)
Exhibit 38: Chart on Blood factors - Year-over-year growth 2021-2026 (%)
Exhibit 39: Data Table on Blood factors - Year-over-year growth 2021-2026 (%)
5.6 Others - Market size and forecast 2021-2026
Exhibit 40: Chart on Others - Market size and forecast 2021-2026 ($ million)
Exhibit 41: Data Table on Others - Market size and forecast 2021-2026 ($ million)
Exhibit 42: Chart on Others - Year-over-year growth 2021-2026 (%)
Exhibit 43: Data Table on Others - Year-over-year growth 2021-2026 (%)
5.7 Market opportunity by Product
Exhibit 44: Market opportunity by Product ($ million)

6 Customer Landscape

6.1 Customer landscape overview
Exhibit 45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

7.1 Geographic segmentation
Exhibit 46: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibit 47: Data Table on Market share By Geographical Landscape 2021-2026 (%)
7.2 Geographic comparison
Exhibit 48: Chart on Geographic comparison
Exhibit 49: Data Table on Geographic comparison
7.3 North America - Market size and forecast 2021-2026
Exhibit 50: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 52: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on North America - Year-over-year growth 2021-2026 (%)
7.4 Europe - Market size and forecast 2021-2026
Exhibit 54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
7.5 Asia - Market size and forecast 2021-2026
Exhibit 58: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 59: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 60: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on Asia - Year-over-year growth 2021-2026 (%)
7.6 Rest of World (ROW) - Market size and forecast 2021-2026
Exhibit 62: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 63: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 64: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
7.7 US - Market size and forecast 2021-2026
Exhibit 66: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibit 67: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibit 68: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on US - Year-over-year growth 2021-2026 (%)
7.8 Germany - Market size and forecast 2021-2026
Exhibit 70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 72: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
7.9 UK - Market size and forecast 2021-2026
Exhibit 74: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 76: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on UK - Year-over-year growth 2021-2026 (%)
7.10 Canada - Market size and forecast 2021-2026
Exhibit 78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 80: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibit 81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
7.11 China - Market size and forecast 2021-2026
Exhibit 82: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibit 83: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibit 84: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibit 85: Data Table on China - Year-over-year growth 2021-2026 (%)
7.12 Market opportunity By Geographical Landscape
Exhibit 86: Market opportunity By Geographical Landscape ($ million)

8 Drivers, Challenges, and Trends

8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges
Exhibit 87: Impact of drivers and challenges in 2021 and 2026
8.4 Market trends

9 Vendor Landscape

9.1 Overview
9.2 Vendor landscape
Exhibit 88: Overview on Criticality of inputs and Factors of differentiation
9.3 Landscape disruption
Exhibit 89: Overview on factors of disruption
9.4 Industry risks
Exhibit 90: Impact of key risks on business

10 Vendor Analysis

10.1 Vendors covered
Exhibit 91: Vendors covered
10.2 Market positioning of vendors
Exhibit 92: Matrix on vendor position and classification
10.3 ADMA Biologics Inc.
Exhibit 93: ADMA Biologics Inc. - Overview
Exhibit 94: ADMA Biologics Inc. - Business segments
Exhibit 95: ADMA Biologics Inc. - Key offerings
Exhibit 96: ADMA Biologics Inc. - Segment focus
10.4 Bio Products Laboratory Ltd.
Exhibit 97: Bio Products Laboratory Ltd. - Overview
Exhibit 98: Bio Products Laboratory Ltd. - Product / Service
Exhibit 99: Bio Products Laboratory Ltd. - Key offerings
10.5 CSL Ltd.
Exhibit 100: CSL Ltd. - Overview
Exhibit 101: CSL Ltd. - Business segments
Exhibit 102: CSL Ltd. - Key news
Exhibit 103: CSL Ltd. - Key offerings
Exhibit 104: CSL Ltd. - Segment focus
10.6 Grifols SA
Exhibit 105: Grifols SA - Overview
Exhibit 106: Grifols SA - Business segments
Exhibit 107: Grifols SA - Key offerings
Exhibit 108: Grifols SA - Segment focus
10.7 Kamada Ltd.
Exhibit 109: Kamada Ltd. - Overview
Exhibit 110: Kamada Ltd. - Product / Service
Exhibit 111: Kamada Ltd. - Key offerings
10.8 Kedrion Spa
Exhibit 112: Kedrion Spa - Overview
Exhibit 113: Kedrion Spa - Product / Service
Exhibit 114: Kedrion Spa - Key offerings
10.9 Octapharma AG
Exhibit 115: Octapharma AG - Overview
Exhibit 116: Octapharma AG - Product / Service
Exhibit 117: Octapharma AG - Key offerings
10.10 Prothya Biosolutions Netherlands BV
Exhibit 118: Prothya Biosolutions Netherlands BV - Overview
Exhibit 119: Prothya Biosolutions Netherlands BV - Product / Service
Exhibit 120: Prothya Biosolutions Netherlands BV - Key offerings
10.11 SK Discovery Co. Ltd.
Exhibit 121: SK Discovery Co. Ltd. - Overview
Exhibit 122: SK Discovery Co. Ltd. - Product / Service
Exhibit 123: SK Discovery Co. Ltd. - Key offerings
10.12 Takeda Pharmaceutical Co. Ltd.
Exhibit 124: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibit 125: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibit 126: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibit 127: Takeda Pharmaceutical Co. Ltd. - Key offerings

11 Appendix

11.1 Scope of the report
11.2 Inclusions and exclusions checklist
Exhibit 128: Inclusions checklist
Exhibit 129: Exclusions checklist
11.3 Currency conversion rates for US$
Exhibit 130: Currency conversion rates for US$
11.4 Research methodology
Exhibit 131: Research methodology
Exhibit 132: Validation techniques employed for market sizing
Exhibit 133: Information sources
11.5 List of abbreviations
Exhibit 134: List of abbreviations

Exhibits

Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Product
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Product - Market share 2021-2026 (%)
Exhibits25: Data Table on Product - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Product
Exhibits27: Data Table on Comparison by Product
Exhibits28: Chart on Immunoglobulin - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Immunoglobulin - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Immunoglobulin - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Immunoglobulin - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Albumin - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Albumin - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Albumin - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Albumin - Year-over-year growth 2021-2026 (%)
Exhibits36: Chart on Blood factors - Market size and forecast 2021-2026 ($ million)
Exhibits37: Data Table on Blood factors - Market size and forecast 2021-2026 ($ million)
Exhibits38: Chart on Blood factors - Year-over-year growth 2021-2026 (%)
Exhibits39: Data Table on Blood factors - Year-over-year growth 2021-2026 (%)
Exhibits40: Chart on Others - Market size and forecast 2021-2026 ($ million)
Exhibits41: Data Table on Others - Market size and forecast 2021-2026 ($ million)
Exhibits42: Chart on Others - Year-over-year growth 2021-2026 (%)
Exhibits43: Data Table on Others - Year-over-year growth 2021-2026 (%)
Exhibits44: Market opportunity by Product ($ million)
Exhibits45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits46: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits47: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits48: Chart on Geographic comparison
Exhibits49: Data Table on Geographic comparison
Exhibits50: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits80: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits82: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits83: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits84: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits85: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits86: Market opportunity By Geographical Landscape ($ million)
Exhibits87: Impact of drivers and challenges in 2021 and 2026
Exhibits88: Overview on Criticality of inputs and Factors of differentiation
Exhibits89: Overview on factors of disruption
Exhibits90: Impact of key risks on business
Exhibits91: Vendors covered
Exhibits92: Matrix on vendor position and classification
Exhibits93: ADMA Biologics Inc. - Overview
Exhibits94: ADMA Biologics Inc. - Business segments
Exhibits95: ADMA Biologics Inc. - Key offerings
Exhibits96: ADMA Biologics Inc. - Segment focus
Exhibits97: Bio Products Laboratory Ltd. - Overview
Exhibits98: Bio Products Laboratory Ltd. - Product / Service
Exhibits99: Bio Products Laboratory Ltd. - Key offerings
Exhibits100: CSL Ltd. - Overview
Exhibits101: CSL Ltd. - Business segments
Exhibits102: CSL Ltd. - Key news
Exhibits103: CSL Ltd. - Key offerings
Exhibits104: CSL Ltd. - Segment focus
Exhibits105: Grifols SA - Overview
Exhibits106: Grifols SA - Business segments
Exhibits107: Grifols SA - Key offerings
Exhibits108: Grifols SA - Segment focus
Exhibits109: Kamada Ltd. - Overview
Exhibits110: Kamada Ltd. - Product / Service
Exhibits111: Kamada Ltd. - Key offerings
Exhibits112: Kedrion Spa - Overview
Exhibits113: Kedrion Spa - Product / Service
Exhibits114: Kedrion Spa - Key offerings
Exhibits115: Octapharma AG - Overview
Exhibits116: Octapharma AG - Product / Service
Exhibits117: Octapharma AG - Key offerings
Exhibits118: Prothya Biosolutions Netherlands BV - Overview
Exhibits119: Prothya Biosolutions Netherlands BV - Product / Service
Exhibits120: Prothya Biosolutions Netherlands BV - Key offerings
Exhibits121: SK Discovery Co. Ltd. - Overview
Exhibits122: SK Discovery Co. Ltd. - Product / Service
Exhibits123: SK Discovery Co. Ltd. - Key offerings
Exhibits124: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits125: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits126: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits127: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits128: Inclusions checklist
Exhibits129: Exclusions checklist
Exhibits130: Currency conversion rates for US$
Exhibits131: Research methodology
Exhibits132: Validation techniques employed for market sizing
Exhibits133: Information sources
Exhibits134: List of abbreviations